decreased response lymphocytes atopic subjects agents intracellular cyclic adenosine monophosphate inhibitory effect prostaglandin histamine isobutylmethylxanthine OH mitogenic stimulation peripheral blood lymphocytes normal atopic subjects atopic patients susceptible inhibition agents intracellular cyclic adenosine monophosphate cAMP concentrations active metabolite vitamin inhibition atopic patients normal donors agents inhibitory effect cAMP-elevating agents addition OH lymphocyte cultures potentiation pronounced lymphocytes atopic donors responsiveness levels comparable levels lymphocytes normal donors synthetic corticosteroid dexamethasone similar potentiating effect inhibitory action prostaglandin view beneficial action beta-agonists phosphodiesterase inhibitors corticosteroids treatment allergy effect OH action cAMP-elevating agents therapeutic interest 